C Chiatti, S Bustacchini, G Furneri, L Mantovani… - Drug safety, 2012 - Springer
Adverse drug events (ADEs) are an increasingly relevant issue for healthcare systems as they are associated with poorer health outcomes and avoidable misuse of resources. The …
A 2003 article titled “It's the Prices, Stupid,” and coauthored by the three of us and the recently deceased Uwe Reinhardt found that the sizable differences in health spending …
Z Song, DG Safran, BE Landon, Y He… - … England Journal of …, 2011 - Mass Medical Soc
Background In 2009, Blue Cross Blue Shield of Massachusetts (BCBS) implemented a global payment system called the Alternative Quality Contract (AQC). Provider groups in the …
This chapter provides a conceptual and empirical examination of health care spending growth (as opposed to the level of health care spending). Given that an equilibrium …
A Dunn, AH Shapiro - The Journal of Law and Economics, 2014 - journals.uchicago.edu
We study the degree to which greater physician concentration leads to higher service prices charged by physicians in the commercially insured medical care market. Using a database …
This book provides a balanced assessment of pay for performance (P4P), addressing both its promise and its shortcomings. P4P programs have become widespread in health care in …
This paper investigates the impact of the macroeconomy on the health insurance coverage of Americans using panel data from the Survey of Income and Program Participation for …
The main rationale for using biosimilar drugs is for cost saving. The market development for biosimilar drugs will therefore depend on the degree to which cost saving measures are …
CR Gowen III, KL McFadden, S Settaluri - American Journal of …, 2012 - emerald.com
Purpose–Rapidly rising healthcare costs, partially due to preventable medical errors, have led hospitals to redouble their process improvement (PI) efforts. The purpose of this paper is …